Fig. 5: Nanoparticle radioenhancement in vitro. | Nature Communications

Fig. 5: Nanoparticle radioenhancement in vitro.

From: Catalytic activity imperative for nanoparticle dose enhancement in photon and proton therapy

Fig. 5

Dose modifying ratios at 50% cell survival (DMR50%) observed in vitro with different nominal nanoparticle concentrations of SiO2 (a), TiO2 (b), TiN (c), WO3 (d), HfO2 (e), and Au (f) nanoparticles in HT1080 cells; data extracted from survival curve with n = 15 independent biological samples (3 samples per X-ray dose) and expressed as mean ± SD from at least 2 independent cell batches.

Back to article page